Literature DB >> 16210786

Involvement of peroxiredoxin I in protecting cells from radiation-induced death.

Bo Zhang1, Yongping Su, Guoping Ai, Yan Wang, Tao Wang, Fengchao Wang.   

Abstract

Peroxiredoxin I (Prx-I), a key member of the peroxiredoxin family, reduces peroxides and equivalents through the thioredoxin system. Our previous work has shown that expression of Prx-I in mammalian cells increases following ionizing radiation (IR), indicating that Prx-I actively responds to IR-induced reactive oxygen species (ROS) and suggesting that Prx-I plays an important role in protecting cells from IR-induced death. To test this hypothesis, we suppressed the expression of Prx-I in SW480 cells by RNA interference. Our results show that IR induces the expression of Prx-I in SW480 cells in a dose- and time-dependent manner. The recombinant siRNA vector targeting Prx-I dramatically reduced the expression of Prx-I in SW480 cells. When Prx-I was knocked down in SW480 cells, the cells exhibited a decreased growth rate, a reduced antioxidant capability following IR and became more sensitive to IR-induced apoptosis. Together, our results demonstrate that Prx-I plays an important role in protecting cells from IR-induced cell death, which might be through scavenging IR-induced ROS in the cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210786     DOI: 10.1269/jrr.46.305

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  15 in total

1.  Radioprotective effect of lactoferrin in mice exposed to sublethal X-ray irradiation.

Authors:  Li Feng; Jianguo Li; Ling Qin; Dan Guo; Hongyu Ding; Daping Deng
Journal:  Exp Ther Med       Date:  2018-08-03       Impact factor: 2.447

2.  Measurement of peroxiredoxin activity.

Authors:  Kimberly J Nelson; Derek Parsonage
Journal:  Curr Protoc Toxicol       Date:  2011-08

3.  Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy.

Authors:  Ana P D Demasi; Ana F Costa; Albina Altemani; Cristiane Furuse; Ney S Araújo; Vera C Araújo
Journal:  Int J Exp Pathol       Date:  2010-01-21       Impact factor: 1.925

4.  Peroxiredoxin I expression in epithelial cells of buccal mucosa from patients exposed to panoramic X-rays: influence of the age.

Authors:  Milena B Silva; Ana P D Demasi; Elizabeth F Martinez; Maristane L Goudinho; Joarlene M Soares; José L C Junqueira; Ney S Araujo
Journal:  Clin Oral Investig       Date:  2017-10-23       Impact factor: 3.573

5.  Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair.

Authors:  Kyung Wha Lee; Doo Jae Lee; Joo Young Lee; Dong Hoon Kang; Jongbum Kwon; Sang Won Kang
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

6.  Silencing Prx1 and/or Prx5 sensitizes human esophageal cancer cells to ionizing radiation and increases apoptosis via intracellular ROS accumulation.

Authors:  Mai-cang Gao; Xiao-di Jia; Qi-fei Wu; Yan Cheng; Fen-rong Chen; Jun Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-04       Impact factor: 6.150

7.  Anti-inflammatory effects of ozonated water in an experimental mouse model.

Authors:  Kazuo Azuma; Takuro Mori; Kinya Kawamoto; Kohei Kuroda; Takeshi Tsuka; Tomohiro Imagawa; Tomohiro Osaki; Fumio Itoh; Saburo Minami; Yoshiharu Okamoto
Journal:  Biomed Rep       Date:  2014-05-26

8.  Peroxiredoxin 3 is resistant to oxidation-induced apoptosis of Hep-3b cells.

Authors:  Y-G Wang; L Li; C-H Liu; S Hong; M-J Zhang
Journal:  Clin Transl Oncol       Date:  2013-10-09       Impact factor: 3.405

9.  Peroxiredoxin III protein expression is associated with platinum resistance in epithelial ovarian cancer.

Authors:  Xin-yan Wang; Hai-jiao Wang; Xiu-qin Li
Journal:  Tumour Biol       Date:  2013-04-06

10.  Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2).

Authors:  Pameeka S Smith-Pearson; Mitra Kooshki; Douglas R Spitz; Leslie B Poole; Weiling Zhao; Mike E Robbins
Journal:  Free Radic Biol Med       Date:  2008-07-27       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.